NZ589981A - Cattle vaccines comprising a disrupted M. bovis bacterium - Google Patents

Cattle vaccines comprising a disrupted M. bovis bacterium

Info

Publication number
NZ589981A
NZ589981A NZ589981A NZ58998109A NZ589981A NZ 589981 A NZ589981 A NZ 589981A NZ 589981 A NZ589981 A NZ 589981A NZ 58998109 A NZ58998109 A NZ 58998109A NZ 589981 A NZ589981 A NZ 589981A
Authority
NZ
New Zealand
Prior art keywords
disrupted
pathogenic
bovis
bovis bacteria
live non
Prior art date
Application number
NZ589981A
Other languages
English (en)
Inventor
Ricardo Rosenbusch
Nakhyung Lee
Original Assignee
Univ Iowa State Res Found Inc
Biotechnology Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa State Res Found Inc, Biotechnology Res & Dev filed Critical Univ Iowa State Res Found Inc
Publication of NZ589981A publication Critical patent/NZ589981A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ589981A 2008-07-03 2009-06-03 Cattle vaccines comprising a disrupted M. bovis bacterium NZ589981A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7826508P 2008-07-03 2008-07-03
PCT/US2009/046135 WO2010002537A1 (en) 2008-07-03 2009-06-03 Cattle vaccines

Publications (1)

Publication Number Publication Date
NZ589981A true NZ589981A (en) 2012-11-30

Family

ID=41466274

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ589981A NZ589981A (en) 2008-07-03 2009-06-03 Cattle vaccines comprising a disrupted M. bovis bacterium

Country Status (6)

Country Link
US (1) US8586059B2 (de)
EP (1) EP2320943B1 (de)
AU (1) AU2009265092B2 (de)
CA (1) CA2729080C (de)
NZ (1) NZ589981A (de)
WO (1) WO2010002537A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
CN102202685A (zh) 2008-10-31 2011-09-28 贝林格尔.英格海姆维特梅迪卡有限公司 包含来自牛枝原体的抗原的多种抗原在多价疫苗组合物中的用途
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
RU2521651C1 (ru) * 2013-04-15 2014-07-10 Федеральное государственное бюджетное учреждение "Федеральный Центр токсикологической, радиационной и биологической безопасности" (ФГБУ "ФЦТРБ-ВНИВИ") ШТАММ БАКТЕРИЙ, Moraxella bovoculi "СХ-Ч6 N-ДЕП" ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ ДИАГНОСТИКУМОВ И ВАКЦИН ПРОТИВ ИНФЕКЦИОННОГО КЕРАТОКОНЪЮКТИВИТА КРУПНОГО РОГАТОГО СКОТА
US9592283B2 (en) * 2014-03-25 2017-03-14 Merial, Inc. Immunological compositions containing attenuated Histophilus somni
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN110483626A (zh) * 2019-08-23 2019-11-22 山东省农业科学院奶牛研究中心 牛支原体膜蛋白p59作为抗原蛋白的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566121B1 (en) * 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
US20060292135A1 (en) * 1997-10-31 2006-12-28 Lawrence Loomis Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
JP2003513935A (ja) 1999-11-08 2003-04-15 バイオミューン マイコプラズマ・ボビスに対するワクチンおよび使用方法
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
US20030082591A1 (en) * 2001-07-24 2003-05-01 Donald Awrey Methods for gene disruption and uses thereof
AU2004289953B2 (en) * 2003-06-18 2008-09-25 Genelux Corporation Modified recombinant vaccina viruses and other microorganisms, uses thereof

Also Published As

Publication number Publication date
CA2729080C (en) 2018-09-11
EP2320943B1 (de) 2016-02-17
CA2729080A1 (en) 2010-01-07
WO2010002537A1 (en) 2010-01-07
AU2009265092A1 (en) 2010-01-07
US8586059B2 (en) 2013-11-19
AU2009265092B2 (en) 2015-09-03
EP2320943A1 (de) 2011-05-18
EP2320943A4 (de) 2012-07-18
US20110150933A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium
PH12014501835A1 (en) Novel adjuvant compositions
PH12017500056A1 (en) Agricultural methods
MX2011011505A (es) Vacuna neumococica y usos de la misma.
AR112198A2 (es) Bacteria rhamnosus fermentum con actividad antifúngica
IN2012DN01898A (de)
MY152711A (en) Oral compositions containing a combination of natural extracts and related methods
MX2013007657A (es) Oligodesoxinucleotidos inmunoestimulantes.
MX2012008717A (es) Composiciones para el cuidado oral.
MX2011010976A (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
MX361945B (es) Metodos y composiciones de fermentacion bacteriana.
EA201500054A1 (ru) Аттенуированные вакцины против streptococcus suis и способы их получения и применения
PH12014501369A1 (en) Oral care compositions
MX2010000864A (es) Vacuna de celulas enteras estafilococcicas inactivadas.
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
MX2010002867A (es) Cepas de micoplasma atenuadas vivas.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
SG194167A1 (en) Oral care composition for treating dry mouth
PL386175A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
AR093424A1 (es) Vacunas atenuadas de mannheimia haemolytica y metodos para su elaboracion y uso
GB2515222A (en) Use of flagellin as a vaccine
BR112015011944A8 (pt) linhagem bacteriana atenuada estável, seus usos e método para sua geração, composição de vacina
GB0900974D0 (en) Mutant pathogenic bacteria and live attenuated vaccine compositions
CL2015000497A1 (es) Cuidado oral.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 JUN 2016 BY THOMSON REUTERS

Effective date: 20130704

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2017 BY THOMSON REUTERS

Effective date: 20160512

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2018 BY THOMSON REUTERS

Effective date: 20170527

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2019 BY THOMSON REUTERS

Effective date: 20180509

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2020 BY THOMSON REUTERS

Effective date: 20190516

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2021 BY THOMSON REUTERS

Effective date: 20200517

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2022 BY THOMSON REUTERS

Effective date: 20210505

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2023 BY THOMSON REUTERS

Effective date: 20220503

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2024 BY THOMSON REUTERS

Effective date: 20230501

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2025 BY THOMSON REUTERS

Effective date: 20240502